Barclays’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-13,144
| Closed | -$1.73M | – | 4031 |
|
|
2020
Q4 | $1.73M | Sell |
13,144
-762
| -5% | -$100K | ﹤0.01% | 1659 |
|
|
2020
Q3 | $704K | Buy |
13,906
+2,234
| +19% | +$113K | ﹤0.01% | 2122 |
|
|
2020
Q2 | $557K | Buy |
11,672
+4,149
| +55% | +$198K | ﹤0.01% | 2274 |
|
|
2020
Q1 | $369K | Sell |
7,523
-18,834
| -71% | -$924K | ﹤0.01% | 2266 |
|
|
2019
Q4 | $1.51M | Sell |
26,357
-5,671
| -18% | -$326K | ﹤0.01% | 2043 |
|
|
2019
Q3 | $1.15M | Buy |
32,028
+4,510
| +16% | +$162K | ﹤0.01% | 2169 |
|
|
2019
Q2 | $855K | Sell |
27,518
-6,574
| -19% | -$204K | ﹤0.01% | 2439 |
|
|
2019
Q1 | $799K | Buy |
34,092
+18,392
| +117% | +$431K | ﹤0.01% | 2314 |
|
|
2018
Q4 | $216K | Sell |
15,700
-1,816
| -10% | -$25K | ﹤0.01% | 2691 |
|
|
2018
Q3 | $175K | Buy |
+17,516
| New | +$175K | ﹤0.01% | 3137 |
|